CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (5,029)	$ (2,227)
Depreciation and amortization	453	84
Stock-based compensation	852	0
Loss on convertible notes, net	0	458
Inventory write-downs and losses on firm purchase commitments	696	31
Other non-cash activities	87	29
Changes in operating assets and liabilities:
Accounts receivable	(82)	0
Inventory	(1,203)	(157)
Other current assets	1	(25)
Other non-current assets	(14)	(6)
Accounts payable and accrued liabilities	479	257
Other current liabilities	97	19
Other non-current liabilities	57	1
Net cash used in operating activities	(3,606)	(1,536)
Cash flows from investing activities:
Capital expenditures	(1,075)	(1,338)
Net cash used in investing activities	(1,075)	(1,338)
Cash flows from financing activities:
Proceeds from issuance of capital stock including employee stock purchase plan	65	2,654
Proceeds from issuance of convertible notes	0	2,500
Principal payments and other financing activities	(3)	(86)
Net cash provided by financing activities	62	5,068
Effect of exchange rate changes on cash and cash equivalents	(4)	0
Net change in cash	(4,623)	2,194
Cash, cash equivalents, and restricted cash—Beginning of period	18,423	3,011
Cash, cash equivalents, and restricted cash—End of period	13,800	5,205
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	374	493
Right-of-use assets obtained in exchange for operating lease liabilities	$ 104	$ 135